EAMA
PPH icon

EFG Asset Management (Americas)’s VanEck Pharmaceutical ETF PPH Stock Holding History

EFG Asset Management (Americas)’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-370
Closed -$22K – 138
2014
Q1 		$22K Hold
370
– – 0.02% 105
2013
Q4 		$19.6K Buy
+370
New +$18.7K 0.02% 100

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MIM
Macroview Investment Management Bethesda, Maryland $144M AUM 19.29% 1-Year Est. Return
CC
Columbia Capital Fullerton, California $91.6M AUM 27.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return

EFG Asset Management (Americas)'s PPH Position: Q2 2014 in Review

EFG Asset Management (Americas) sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2014, closing a stake of 370 shares — an estimated $22K sold.

EFG Asset Management (Americas) first reported a position in PPH in Q4 2013 and held it in 2 quarters. The position peaked at $22K in Q1 2014. 54 funds tracked by Wall St. Rank hold PPH as of Q2 2014.

  • EFG Asset Management (Americas) reported no remaining VanEck Pharmaceutical ETF position as of Q2 2014 after selling out during the quarter.
  • EFG Asset Management (Americas) sold 370 VanEck Pharmaceutical ETF shares in Q2 2014, an estimated $22K.
  • EFG Asset Management (Americas) first reported a position in VanEck Pharmaceutical ETF in Q4 2013 and held it in 2 quarters.
  • EFG Asset Management (Americas)'s VanEck Pharmaceutical ETF position peaked at $22K in Q1 2014.
  • 54 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2014.

Based on EFG Asset Management (Americas)'s 13F filing for Q2 2014, filed 30 Jul 2014.